Which Weight Loss Drug Works Best for You?
Weight Loss Drug Wegovy vs Mounjaro: The Key Differences
The weight loss drug Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety. Mounjaro (tirzepatide) takes a different approach, targeting both GLP-1 and GIP receptors for dual-hormone weight management support. This fundamental difference in mechanism means some patients may respond better to one treatment over the other, which is why having both options available through EverydayMeds provides significant clinical advantage. Your prescriber can assess your individual medical history, current medications, and weight loss goals to recommend the most appropriate option.
The dosing schedules also differ significantly between these weight loss medications. Wegovy follows a 5-step escalation from 0.25mg to 2.4mg maintenance dose over 16 weeks, whilst Mounjaro uses a 6-step progression from 2.5mg to 15mg maximum dose. Both require once-weekly injections using pre-filled FlexTouch pens, but the gradual dose increases help minimise potential gastrointestinal side effects that can occur with GLP-1 based treatments.
Transparent Pricing for Weight Loss Drug Wegovy and Mounjaro
EverydayMeds offers competitive pricing for both weight loss treatments with no hidden fees. The weight loss drug Wegovy starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the 2.4mg maintenance dose. Our convenient bundle options include the Intro Duo (0.25mg & 0.5mg) at £169.99, and the Gentle Start Trio (0.25mg, 0.25mg, 0.5mg) at £269.99 for patients preferring slower dose escalation. New customers receive code FIRST40 at checkout, whilst returning customers use code DOSE25.
Mounjaro pricing reflects its higher manufacturing costs, starting at £119.99 for 2.5mg and reaching £249.99 for the 15mg maintenance dose. Both treatments require ongoing monthly supply for sustained weight management, making bundle purchasing particularly convenient for avoiding supply interruptions. Our Ultimate Stability Trio provides three months of Wegovy 2.4mg maintenance supply for £649.99, ensuring consistent treatment without multiple ordering cycles.
Clinical Evidence Supporting Weight Loss Drug Wegovy
In the landmark STEP 1 clinical trial, patients taking the weight loss drug Wegovy alongside a reduced-calorie diet and increased physical activity achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 study demonstrated sustained weight loss of 15.2% at two years, indicating long-term efficacy when treatment continues. These results led to NICE TA875 approval, recommending Wegovy with specialist weight management support.
Recent SELECT cardiovascular outcomes data showed Wegovy may reduce major adverse cardiovascular events by 20% (hazard ratio 0.80), suggesting benefits beyond weight management. However, individual results vary significantly, and the weight loss drug Wegovy works most effectively when combined with dietary modifications and increased physical activity as part of comprehensive lifestyle changes.
How Weight Loss Drug Wegovy Works in Your Body
Wegovy contains semaglutide, which mimics the action of GLP-1 (glucagon-like peptide-1), a hormone naturally produced in your intestines after eating. This weight loss drug works by binding to GLP-1 receptors in your brain's appetite control centres, specifically the hypothalamus, reducing hunger signals and increasing feelings of fullness after smaller meals. The medication also slows gastric emptying, meaning food stays in your stomach longer, contributing to sustained satiety between meals. Additionally, Wegovy may help reduce food cravings and the psychological drive to eat, particularly for high-calorie foods. This multi-faceted approach addresses both physiological hunger and behavioural eating patterns that contribute to weight gain.
Simple Ordering Process for Weight Loss Drug Wegovy
Accessing the weight loss drug Wegovy through EverydayMeds begins with our comprehensive 3-minute online clinical assessment, covering your medical history, current medications, weight loss goals, and lifestyle factors. Our qualified prescribers review your application within standard 3 working days, or express 24-hour service for urgent requirements. Once approved, your prescription-only medicine ships via next-day cold-chain delivery, maintaining the required 2-8°C temperature throughout transit. Our patient support team remains available for ongoing guidance about injection technique, dose escalation timing, and managing any side effects. The entire process maintains complete privacy and discretion, with discreet packaging for all deliveries.
Storage and Practical Considerations for Weight Loss Drug Wegovy
The weight loss drug Wegovy requires refrigerated storage at 2-8°C before first use, but offers exceptional travel flexibility with 6 weeks room temperature stability below 30°C once removed from the fridge. This significant advantage over Mounjaro's 21-day room temperature limit makes Wegovy particularly suitable for frequent travellers or those with inconsistent refrigeration access. Each FlexTouch pen contains 4 doses for once-weekly injection, with dose escalation occurring every 4 weeks according to the structured protocol. The mandatory dose escalation cannot be rushed or skipped, as this increases risk of gastrointestinal side effects. Proper injection site rotation between thigh, abdomen, and upper arm helps prevent lipodystrophy and maintains consistent absorption of this prescription-only medicine.
Wegovy vs Mounjaro: Storage and Lifestyle Compatibility
When comparing weight loss drug options, practical considerations often influence long-term treatment adherence. Wegovy's superior 6-week room temperature stability makes it ideal for business travellers, students, or anyone with unpredictable schedules who might struggle with strict refrigeration requirements. Mounjaro's 21-day room temperature limit requires more careful planning for holidays or work trips. Both medications use similar FlexTouch pen technology, but the different dose escalation schedules mean Mounjaro patients reach higher absolute doses, which some find more reassuring psychologically.
The injection experience differs slightly between treatments, with some patients reporting Mounjaro's higher volume injections feel more substantial. However, both weight loss drugs require commitment to once-weekly dosing, and missing doses can impact efficacy. Our clinical team provides detailed guidance on managing both options, helping you choose based on your lifestyle, travel requirements, and personal preferences rather than assuming one treatment is universally superior.
Start Your Weight Loss Journey with Expert Support
EverydayMeds uniquely offers both weight loss drug Wegovy and Mounjaro through our GPhC-registered pharmacy (#9012878), ensuring you access the most appropriate treatment for your individual circumstances. Our discount codes FIRST40 (new customers) and DOSE25 (returning customers) apply automatically at checkout, providing transparent pricing without hidden fees. Begin your assessment today at https://everydaymeds.co.uk/collections/weight-loss to compare both options with expert clinical guidance. Remember that both treatments are prescription-only medicines requiring ongoing medical supervision and work most effectively alongside a reduced-calorie diet and increased physical activity. Our comprehensive support ensures you make an informed decision between these proven weight management options.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
